Clinical Trials Directory

Trials / Completed

CompletedNCT00815984

Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases

FeNO Result Prediction Factors in Children With Allergic Diseases

Status
Completed
Phase
Study type
Observational
Enrollment
800 (actual)
Sponsor
Medical University of Lodz · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Not accepted

Summary

In about 800 children with allergic diseases (asthma, allergic rhinitis, atopic dermatitis) the investigators will retrospectively and cross-sectionally analyze the influence/correlation of diagnosis, treatment methods, allergy status (skin prick test results), lung function tests results on/with the concentration of nitric oxide in exhaled breath.

Detailed description

In about 800 children with allergic diseases from our Outpatient Clinic (asthma, allergic rhinitis, atopic dermatitis) we will retrospectively and cross-sectionally analyse the influence/correlation of diagnosis, treatment methods, allergy status (skin prick test results), lung function tests results on/with the concentration of nitric oxide in exhaled breath.

Conditions

Interventions

TypeNameDescription
PROCEDUREmeasurements of lung function testsMeasurement of the concentration of FeNO , measurement of spirometry, plethysmography, exercise challenge test (ECT -spirometric), bronchial obstruction reversibility pharmacological test

Timeline

Start date
2009-01-01
Primary completion
2010-01-01
Completion
2010-01-01
First posted
2008-12-31
Last updated
2010-02-10

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT00815984. Inclusion in this directory is not an endorsement.